STOCK MARKETS

Lumentum’s sales surged 137%—so why is its stock crashing? RSS CTA

By Investing.com RSS CTA5 min readInvesting.com
Lumentum’s sales surged 137%—so why is its stock crashing? RSS CTA

Lumentum’s sales surged 137%—so why is its stock crashing?

Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

 The AI chip trade has unraveled this month. Intel’s weak forecast set off a broad semiconductor sell-off, and Marvell Technology (NASDAQ:MRVL) had already slid about 22% between the first reports of its $115 billion bid for Lumentum and the deal’s announcement. Even Lumentum Holdings (NASDAQ:LITE)—the laser maker supplying the optical links inside AI data centers—has plunged 34.0% over the past month to $551.07, including an 11.8% slide in the past week alone.

The headline growth is what makes Lumentum tempting, but the stock no longer trades on its own results. Analysts forecast 121.5% revenue growth and 130.6% EPS growth, yet Marvell’s all-stock agreement pays Lumentum shareholders a fixed 4.5 Marvell shares for each share they own, so every slide in Marvell now lands directly on Lumentum’s price. GAAP earnings also remain negative at -7.6 times trailing earnings, and InvestingPro’s valuation models rate the stock merely "Fair" at $566.14, just 2.7% above the share price. That leaves dip-buyers taking on Marvell’s swings without a valuation cushion of their own.

Knowing when a triple-digit sales growth has not yet reached GAAP earnings is what ProPicks AI is built for. In Tech Titans, InvestingPro’s strategy dedicated to high-margin tech leaders, Lumentum didn’t make the cut: the strategy refused to chase optical-networking hype without GAAP earnings support, keeping members out of the 34% slide and in profitable semiconductor equipment and foundry leaders instead.

The Laser Supplier AI Cannot Get Enough Of

Lumentum makes its money selling the lasers and optical components that carry data between AI servers, and it sells them into a market where demand has outrun supply. It holds dominant share in indium phosphide lasers and high-speed EMLs, commands 70% to 80% of the pump laser market, and is the only merchant supplier of optical circuit switches with a proven shipping track record. Pump laser shipments surged more than 80% year-over-year, backed by three-year take-or-pay agreements with major hyperscalers.

Fiscal fourth-quarter results showed how much that position now earns. Revenue surged 109% year-over-year and 23% sequentially to $1.01 billion, the eighth straight quarter of growth, while non-GAAP gross margin topped 50% for the first time and non-GAAP operating margin expanded 2,160 basis points to 36.6%. The first quarter of fiscal 2027 then beat estimates, with revenue climbing 136.5% year-over-year to $1.26 billion and EPS of $4.57.

The negative trailing multiple stems from a single accounting charge rather than weak operations. A one-time, non-cash $7.8 billion charge from converting convertible debt into equity produced a fourth-quarter GAAP net loss of $7.2 billion, yet first-quarter GAAP net income reached $360.3 million.

Wall Street Cools, Fair Value Holds the Line

Wall Street has turned more cautious since the deal. B. Riley cut Lumentum to Neutral with a $770 target, Stifel moved to Hold at $806, and UBS holds at $686, while Bernstein SocGen still rates it a Buy at $700. Every one of those targets sits above the current share price, and the average analyst target of roughly $1,070 sits far higher. Estimates keep climbing: 16 analysts have revised EPS forecasts higher over the past 90 days with none lower, and consensus calls for $28.41 in fiscal 2027 and $45.84 in fiscal 2028.

InvestingPro’s Fair Value models see far less room to run, placing intrinsic value at $566.14 per share—just 2.7% above the share price and well below the Street’s average target.

The main risk is that Lumentum’s fate is no longer its own. Marvell’s slide has already reduced the implied deal value from the roughly $1,132 per share it carried at announcement, and closing is not expected until the first half of 2028, subject to stockholder and regulatory approvals that could include China. Investor-rights firms have launched investigations into whether the ratio fairly values Lumentum shareholders, and insiders sold about $86 million of stock in the three months before the announcement.

Before catching a 34% optical-chip falling knife, investors must weigh Lumentum’s laser dominance against a share price now tied to Marvell’s. Hyperscaler customer concentration, GAAP profitability, and deal-integration risks are detailed inside the Lumentum Holdings Pro Research Report.

A Growth Story on Someone Else’s Clock

Lumentum has shown it can turn the AI buildout into record revenue and expanding margins. Until the Marvell deal closes or breaks, though, its share price will track Marvell’s stock and the regulatory calendar more closely than its own order book.

Relying on a single optical-chip stock while AI hardware sentiment swings leaves capital exposed to the deal-driven drawdowns that no earnings beat can offset. Rather than attempting to work out manually which AI suppliers still control their own share price, InvestingPro’s data-driven strategies evaluate thousands of balance sheets every month to isolate tech leaders backing their growth with GAAP profits.

For investors seeking high-conviction ideas in the active November lineup, full access to all ProPicks AI strategies costs just $9 a month.

With the next monthly ProPicks AI rebalance scheduled for December 1, subscribers who join today see every stock the models are holding right now—and get immediate alerts the moment high-risk tickers are cut and new picks go live next month.

 The author holds no position in the stocks mentioned. Share price, performance, P/E, growth forecasts, and Fair Value as of November 19, 2026; financial results, analyst targets, and research data as of November 13, 2026.